Menopause Research Act of 2022

Hozzl · 2022-12-29T12:18:42Z

Explore the details of House Bill 8774 Menopause Research Act of 2022 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/29/2022, 12:18 PM

Summary of Bill HR 8774

Bill 117 hr 8774, also known as the Menopause Research Act of 2022, is a piece of legislation introduced in the US Congress with the aim of addressing the lack of research and understanding surrounding menopause and its impact on women's health. The bill seeks to allocate funding for research into the causes and effects of menopause, as well as potential treatments and therapies to alleviate symptoms.

Specifically, the Menopause Research Act of 2022 calls for the establishment of a dedicated research program within the National Institutes of Health (NIH) to focus on menopause-related issues. This program would be tasked with conducting studies on the hormonal changes that occur during menopause, the long-term health consequences of menopause, and potential interventions to improve women's quality of life during this stage of life.

In addition to funding research, the bill also aims to raise awareness about menopause and its impact on women's health. It calls for the development of educational materials and resources for healthcare providers and the general public to increase understanding and promote better care for women experiencing menopause. Overall, the Menopause Research Act of 2022 represents a bipartisan effort to address a significant gap in women's health research and provide support for women going through menopause. By allocating resources to study this important stage of life, the bill has the potential to improve the quality of care and treatment options available to women experiencing menopause.

Congressional Summary of HR 8774

Menopause Research Act of 2022

This bill directs the National Institutes of Health to conduct or support research and related activities concerning menopause and the health of mid-life women. This includes evaluating past and current research and developing a strategic plan to guide future research.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 8774

Bill HR 8774 is currently in the status of Bill Introduced since September 6, 2022. Bill HR 8774 was introduced during Congress 117 and was introduced to the House on September 6, 2022. Bill HR 8774's most recent activity was Referred to the Subcommittee on Health. as of September 7, 2022

Bipartisan Support of Bill HR 8774

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 8774

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 8774

Menopause Research Act of 2022Menopause Research Act of 2022To require the Director of the National Institutes of Health to conduct an evaluation of menopause-related research (including gaps in research and knowledge regarding the causes, symptoms, and treatments for menopause), to develop a strategic plan to resolve gaps in knowledge and research, and identify topics in need of further research relating to potential treatments for menopause-related symptoms, and for other purposes.

Start holding our government accountable!